New study hopes to unlock Body's natural defense against low blood sugar in type 1 diabetes
NCT ID NCT07373236
First seen Jan 29, 2026 · Last updated May 07, 2026 · Updated 18 times
Summary
This study looked at whether blocking a hormone called GLP-1 can help people with type 1 diabetes release glucagon, a hormone that raises blood sugar when it gets too low. In type 1 diabetes, the body loses this natural safeguard, raising the risk of dangerous low blood sugar (hypoglycemia). Researchers tested this idea in 12 adults with type 1 diabetes by giving them a substance that blocks GLP-1 and measuring their glucagon levels. The goal was to see if this approach could lead to a new treatment to reduce hypoglycemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gentofte Hospital
Hellerup, 2100, Denmark
Conditions
Explore the condition pages connected to this study.